renal transplantation niertransplantatie protocol biopsy protocollaire biopsy Immunosuppression immunosuppressie IF/TA interstitiele fibrose, tubulesatrofie
Conditions
Interventions
None listed
Sponsors
MUMC+
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients transplanted between 2003 and February 2008; 2. An adequate T0 and T12 biopsy; 3. Tacrolimus-based regimen with either SRL or MMF; 4. Age between 18 and 80 years.
Exclusion criteria
Exclusion criteria: 1. Other immunosuppressive regimen than tacrolimus, either SRL or MMF; 2. Patients with missing biopsies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression in IF/TA (Chamge in IF/TA between implantation and at month 12. | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors associated with this progression. | — |
Contacts
Public ContactMarielle Gelens
Postbus 5800
Outcome results
None listed